25.10.2017 23:14:41
|
Vertex Pharmaceuticals Inc. Earnings Rise 216% In Q3
(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) revealed a profit for its third quarter that rose from last year.
The company said its bottom line totaled $136 million, or $0.53 per share. This was up from $43 million, or $0.17 per share, in last year's third quarter.
Analysts had expected the company to earn $0.31 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company said revenue for the quarter rose 39.7% to $578.17 million. This was up from $413.78 million last year.
Vertex Pharmaceuticals Inc. earnings at a glance:
-Earnings (Q3): $136 Mln. vs. $43 Mln. last year. -Earnings Growth (Y-o-Y): 216.3% -EPS (Q3): $0.53 vs. $0.17 last year. -EPS Growth (Y-o-Y): 211.8% -Analysts Estimate: $0.31 -Revenue (Q3): $578.17 Mln vs. $413.78 Mln last year. -Revenue Change (Y-o-Y): 39.7%
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Vertex Pharmaceuticals Inc.mehr Nachrichten
Analysen zu Vertex Pharmaceuticals Inc.mehr Analysen
Aktien in diesem Artikel
Vertex Pharmaceuticals Inc. | 439,05 | -1,15% |
|